Policies About Late-Career Physicians Are Considered Successful
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 4, 2024 -- Institutional leaders consider policies about late-career physicians (LCPs; physicians working beyond age 65 to 75 years) to be successful, according to a study published online Nov. 5 in the Annals of Internal Medicine.
Noting that some health care organizations (HCOs) have adopted LCP policies requiring cognitive, physical, and practice performance screening assessments, Andrew A. White, M.D., from the University of Washington School of Medicine in Seattle, and colleagues characterized key features of LCP policies and the perspectives of medical leaders responsible for policy development and implementation. Participants included 21 interviewees in physician leadership roles at 18 HCOs.
The researchers found that policies varied substantially in the testing required, funding, processes after a positive screening result, and decision-making around concerning results; however, they shared many commonalities, including mandatory universal screening at a trigger age around 70 years, a strategy of screening followed by in-depth assessment of positive results, and commitment to patient safety as the key motive. Institutional discretion in interpreting and responding to test results was prioritized in policies; clear language about appeals or other procedural protections for physicians were lacking in many policies. In general, leaders were satisfied with policies but reported preemptive retirements as physicians approached the age of screening.
"Our study identified opportunities to better serve physicians' interests while vigorously promoting the paramount value of patient safety," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-06 00:00
Read more
- Falling Asleep While Feeding Infants Commonly Reported by Mothers
- Rising Temperatures Increase Risk for Poor Maternal, Neonatal Outcomes
- Novartis Scemblix Granted FDA Accelerated Approval in Newly Diagnosed CML
- Prenatal Vitamin D Supplementation Increases Bone Density in Children
- Judge Declares Wyoming's Abortion Bans Unconstitutional
- Onions in McDonalds' Quarter Pounders Linked to E. Coli Outbreak Have Been Recalled
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions